State Street Corp Biotechnology

State Street Corp

$2.36 Trillion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LEXX Lexaria Bioscience Corp.	$5.71M	$67,000 0.0% of portfolio	39,301	Q1 2024 New
LYRA Lyra Therapeutics, Inc.	$255M	$63,000 0.0% of portfolio	488,720	Q3 2024 Added 88.1%
ARMP Armata Pharmaceuticals, Inc.	$90M	$58,000 0.0% of portfolio	40,300	Q3 2023 New
ANVS Annovis Bio, Inc.	$23.9M	$57,000 0.0% of portfolio	38,435	Q4 2024 Added 6.66%
DYAI Dyadic International Inc	$30.7M	$57,000 0.0% of portfolio	42,550	Q4 2024 Reduced 2.3%
PASG Passage Bio, Inc.	$385M	$54,000 0.0% of portfolio	156,773	Q4 2024 Added 26.56%
BCAB Bio Atla, Inc.	$13.4M	$52,000 0.0% of portfolio	151,377	Q4 2024 Added 8.43%
CGTX Cognition Therapeutics Inc	$18.6M	$51,000 0.0% of portfolio	121,850	Q4 2024 Added 94.18%
CVM Cel Sci Corp	$294M	$49,000 0.0% of portfolio	215,207	Q4 2024 Added 11.21%
RLYB Rallybio Corp	$16.7M	$40,000 0.0% of portfolio	62,072	Q3 2024 Reduced 4.83%
GLYC Glycomimetics Inc	$823M	$37,000 0.0% of portfolio	179,265	Q1 2024 Reduced 4.02%
BRTX Bio Restorative Therapies, Inc.	$5.99M	$36,000 0.0% of portfolio	20,459	Q1 2023 New
NXTC Next Cure, Inc.	$163M	$31,000 0.0% of portfolio	65,392	Q2 2024 Added 14.54%
XLO Xilio Therapeutics, Inc.	$18.4M	$31,000 0.0% of portfolio	43,390	Q2 2024 Added 176.55%
ATHA Athira Pharma, Inc.	$16.6M	$30,000 0.0% of portfolio	107,381	Q4 2024 Reduced 0.37%
NERV Minerva Neurosciences, Inc.	$11.3M	$28,000 0.0% of portfolio	16,519	Q3 2023 Added 20.41%
RLMD Relmada Therapeutics, Inc.	$19.2M	$28,000 0.0% of portfolio	106,735	Q4 2024 Added 7.56%
RNXT Renovo Rx, Inc.	$11.5M	$25,000 0.0% of portfolio	26,152	Q2 2024 Added 38.72%
EQ Equillium, Inc.	$13.1M	$23,000 0.0% of portfolio	59,720	Q2 2024 Added 13.49%
AIM Aim Immuno Tech Inc.	$404M	$20,000 0.0% of portfolio	173,103	Q1 2022 Added 7.91%
RPTX Repare Therapeutics Inc.	$65M	$19,000 0.0% of portfolio	19,401	Q1 2025 Reduced 3.03%
BOLT Bolt Biotherapeutics, Inc.	$241M	$18,000 0.0% of portfolio	47,437	Q4 2023 Reduced 2.67%
SPRB Spruce Biosciences, Inc.	$2.83M	$17,000 0.0% of portfolio	60,700	Q4 2024 Reduced 5.75%
ACXP Acurx Pharmaceuticals, Inc.	$5.08M	$16,000 0.0% of portfolio	43,466	Q1 2024 Added 52.16%
INAB In8 Bio, Inc.	$57.8M	$15,000 0.0% of portfolio	88,746	Q2 2024 Added 49.79%
MIST Milestone Pharmaceuticals Inc.	$47.4M	$14,000 0.0% of portfolio	18,537	Q1 2025 Reduced 3.03%
SILO Silo Pharma, Inc.	$1.98M	$14,000 0.0% of portfolio	12,500	Q1 2023 New
SNSE Sensei Biotherapeutics, Inc.	$212M	$10,000 0.0% of portfolio	25,774	Q2 2022 Reduced 88.57%
INDP Indaptus Therapeutics, Inc.	$81.8M	$7,000 0.0% of portfolio	13,073	Q1 2024 Reduced 32.87%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	2,031,234	Q1 2025 Reduced 26.13%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.